Scarica l'app Stockscreener
28.20
0.21%
-0.06
Dopo l'orario di chiusura:
28.20
Precedente Chiudi:
$28.26
Aprire:
$28.095
Volume 24 ore:
215.26K
Relative Volume:
0.36
Capitalizzazione di mercato:
$1.32B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-61.30
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
+1.51%
1M Prestazione:
-0.60%
6M Prestazione:
-34.68%
1 anno Prestazione:
-4.21%
Intervallo 1D:
$27.97
$28.28
Intervallo di 1 settimana:
$26.84
$29.02
Portata 52W:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
28.20 | 1.32B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
What drives Omnicell Inc. stock priceRobust investment performance - jammulinksnews.com
Omnicell Inc. Stock Analysis and ForecastExponentially increasing returns - Autocar Professional
Is Omnicell Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
Robotic Pharmacy Automation System Market Set to Witness - openPR.com
What analysts say about Omnicell Inc. stockDouble-digit growth - jammulinksnews.com
Why Omnicell (OMCL) Stock Is Trading Up Today - TradingView
Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025 - GlobeNewswire Inc.
Published on: 2025-07-18 21:34:02 - jammulinksnews.com
Benchmark reiterates Buy rating on Omnicell stock amid tariff uncertainties By Investing.com - Investing.com Canada
Adherence Packaging Market to Witness Massive Growth by CAGR - openPR.com
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Unexpected Trends Reshaping the Central Fill Pharmacy - openPR.com
Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 - BioSpace
Omnicell's Q2 Outlook: Autonomous Pharmacy Momentum and Undervalued Growth Catalysts - AInvest
Omnicell's Growth Uncertainty Amidst Market Challenges: A Hold Rating Analysis - AInvest
Omnicell to Release Second Quarter 2025 Financial Results on Jul - GuruFocus
Omnicell (OMCL) Faces Target Price Adjustment Amid Revenue Uncer - GuruFocus
A Hidden Reason Omnicell's Future Looks Bright - AOL.com
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Markets | American Financial Group, Inc. - FinancialContent
Medication Management System Market Set to Witness Significant - openPR.com
Omnicell stock maintains Buy rating at Craig-Hallum amid tariff adjustments - Investing.com Canada
3 Reasons to Sell OMCL and 1 Stock to Buy Instead - Yahoo Finance
Automated Medication Compounding System Market Generated - openPR.com
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Pharmacy Automation Devices Market Set to Witness Significant - openPR.com
Learn to Evaluate (OMCL) using the Charts - news.stocktradersdaily.com
Robotic Pharmacy Automation System Market Is Booming So Rapidly - openPR.com
Do Options Traders Know Something About Omnicell Stock We Don't? - The Globe and Mail
Omnicell Inc. to Pay $4.3 Million to Settle VA Overbilling Allegations - USA Herald
VA Contractor To Pay $4.3M To Resolve Overbilling Claims - Law360
Omnicell to pay $4.3M for overbilling VA in Spokane - NonStop Local KHQ
Unit Dose Drug Delivery Systems Market Booming with Hospital Safety Initiatives | Omnicell Inc., Baxter International - openPR.com
New Technology Developments in Robotic Dispensing System - openPR.com
Omnicell Deploys Healthcare Automation to Ease Staff Strain and Elevate Patient Care - MarketScale
Omnicell Tackles Medication Inefficiency with RFID, AI, and a Vision for the Autonomous Pharmacy - MarketScale
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):